US Patent 11945869 PD-1 single domain antibodies and therapeutic compositions thereof
Patent 11945869 was granted and assigned to Inhibrx on April, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11945869 PD-1 single domain antibodies and therapeutic compositions thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
